SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
934 83 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Any one offer insight about the potential of GILD? It just has an AIDS drug approved by FDA.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
934Another 11 m shares for free. When will bleeding stop? When all $35B are spent, Miljenko Zuanic-February 28
933GILD is "toasted" in HCV market!Miljenko Zuanic-February 9
932I've never sold juno, and don't remember if I ever held kite. Wasn'scaram(o)uche-12/14/2017
931Makes me start looking at Juno again. If GILD & NVS end up doing the heavy tuck-12/14/2017
930Five??? I expected issues. But five? Ugh.scaram(o)uche-12/14/2017
929Speaking of Kite, GILD's Yescarta likely to miss early estimates due to reimtuck-12/14/2017
928businesswire.com Gilead buys Cell Design Labs, adding to Kite focus (car-T).scaram(o)uche-12/7/2017
927So Anthem is restricting reimbursement of axicabtagene to patients who meet the tuck-11/9/2017
926i try to follow jacob's missives too, but i agree that was pretty weak analymopgcw-8/30/2017
925EPVantage with a pretty levelheaded take on the pros and cons of the KITE buyouttuck-8/30/2017
924On watch for clear above 67.14. [graphic]hollyhunter-6/5/2017
923Well, I am also holding for now, due to coming Bictegravir P3 data, May-end/midMiljenko Zuanic-5/16/2017
922fwiw, I am still holding for the long haul. if it dips to $60, i will add sharemopgcw-5/15/2017
921From WP article: <Through its Medicaid program, Louisiana covered Sovaldi andMiljenko Zuanic15/11/2017
920gilead & U.S. Code Section 1498: a cautionary tale perhaps? washingtonpost.software salesperson-5/11/2017
919I have no idea what to do with my, relative large, GILD holding? Sell it with loMiljenko Zuanic-5/11/2017
918That priority review voucher could come in handy should they buy a late stage drmore100-2/22/2017
917This stock is giving me flashbacks to when I owned CVX. No one made $$ panic selmore10012/15/2017
916This week we find out if we are going to the 50s or 80s all eyes on HIV. Needs tmore100-2/13/2017
915I concur. the price issue may be sidetracked briefly, but it will not go away. mopgcw-11/9/2016
914Regardless failure of Pro 61 (and today broad bios gain), I do think and believeMiljenko Zuanic-11/9/2016
913REGN too, next year growth will decline...so whole SECTOR (more or less) is at PMiljenko Zuanic111/2/2016
912i conur. they are at a pivot point and the internal allocation of capital needsmopgcw-11/2/2016
911GILD in TROUBLE? It is obvious that to survive (as entity) GILD need to expand Miljenko Zuanic-11/1/2016
910Why not? Waste another 2 years for P2b? IF works...works! If not....did not loseMiljenko Zuanic-10/20/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News - See Terms of Use.